SEC Form 4 · accession 0001225208-17-019019
BARD C R INC /NJ/ · BCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A DeFord
Officer — Sr. VP Sci Tech and Clin Afrs
Period of report
Dec 20, 2017
Accepted (ET)
Dec 22, 2017 · 2:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000009892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 20, 2017 | M | 4,161 | $136.37 | A | 20,950 | D | |
| Common Stock | Dec 20, 2017 | M | 3,767 | $168.865 | A | 24,717 | D | |
| Common Stock | Dec 20, 2017 | M | 3,293 | $186.425 | A | 28,010 | D | |
| Common Stock | Dec 20, 2017 | M | 2,886 | $219.555 | A | 30,896 | D | |
| Common StockF3 | Dec 20, 2017 | S | 900 | $334.1189 | D | 29,996 | D | |
| Common StockF4 | Dec 20, 2017 | S | 13,207 | $333.4341 | D | 16,789 | D | |
| Common StockF5 | holding | — | — | — | 84 | I | 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (Right to Buy)F6,F7 | $186.425 | Dec 20, 2017 | M | 3,293 | D | — | Dec 9, 2025 | Common Stock | 3,293 | 6,586 | D |
| Option (Right to Buy)F6,F8 | $168.865 | Dec 20, 2017 | M | 3,767 | D | — | Dec 10, 2024 | Common Stock | 3,767 | 3,768 | D |
| Option (Right to Buy)F6,F9 | $136.37 | Dec 20, 2017 | M | 4,161 | D | — | Dec 11, 2023 | Common Stock | 4,161 | 0 | D |
| Option (Right to Buy)F6,F10 | $219.555 | Dec 20, 2017 | M | 2,886 | D | — | Dec 14, 2026 | Common Stock | 2,886 | 8,658 | D |
Explanation of responses
- F1Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
- F10Of this option grant 2,886 options vested on December 14, 2017 and the remaining options vest in three annual installments beginning on December 14, 2018.
- F2Includes 0.0887 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 0.0020 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017.
- F3Represents the weighted average sales price for price increments ranging from $333.97 to $334.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F4Represents the weighted average sales price for price increments ranging from $332.96 to $333.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- F5Includes 3.904 shares acquired under the Company's 401(k) Plan from May 4, 2017 to August 4, 2017.
- F6Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
- F7Of this option grant 3,293 options vested on December 9, 2017 and the remaining options vest in two annual installments beginning on December 9, 2018.
- F8Of this option grant 3,767 options vested on December 10, 2017 and the remaining options vest on December 10, 2018.
- F9Options vested on December 11, 2017.